Franklin Resources
CNTA

Franklin Resources’s Centessa Pharmaceuticals CNTA Stock Holding History

Franklin Resources’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.2M Sell
684,482
-1,683,899
-71% -$43.1M 0.01% 865
2025
Q4 		$59.2M Sell
2,368,381
-190,033
-7% -$4.81M 0.01% 592
2025
Q3 		$62M Buy
2,558,414
+14,875
+0.6% +$264K 0.02% 566
2025
Q2 		$33.4M Buy
2,543,539
+1,540
+0.1% +$19.5K 0.01% 758
2025
Q1 		$36.6M Buy
2,541,999
+233,453
+10% +$3.82M 0.01% 711
2024
Q4 		$38.7M Buy
2,308,546
+6,000
+0.3% +$99.4K 0.01% 696
2024
Q3 		$38.4M Buy
2,302,546
+1,145,823
+99% +$14M 0.01% 685
2024
Q2 		$10.4M Hold
1,156,723
– – ﹤0.01% 1063
2024
Q1 		$13.1M Buy
1,156,723
+40,906
+4% +$387K ﹤0.01% 993
2023
Q4 		$8.88M Buy
1,115,817
+283,469
+34% +$1.9M ﹤0.01% 962
2023
Q3 		$5.39M Hold
832,348
– – ﹤0.01% 1070
2023
Q2 		$5.15M Hold
832,348
– – ﹤0.01% 1107
2023
Q1 		$3.2M Hold
832,348
– – ﹤0.01% 1231
2022
Q4 		$2.58M Sell
832,348
-584
-0.1% -$2.17K ﹤0.01% 1303
2022
Q3 		$3.35M Hold
832,932
– – ﹤0.01% 1191
2022
Q2 		$4.06M Buy
832,932
+216,029
+35% +$1.38M ﹤0.01% 1158
2022
Q1 		$5.53M Buy
616,903
+41,365
+7% +$377K ﹤0.01% 1144
2021
Q4 		$6.48M Sell
575,538
-346,562
-38% -$4.66M ﹤0.01% 1163
2021
Q3 		$15.4M Sell
922,100
-600
-0.1% -$12.4K 0.01% 954
2021
Q2 		$20.5M Buy
+922,700
New +$21.7M 0.01% 850

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Franklin Resources's CNTA Position: Q1 2026 in Review

Franklin Resources reduced its Centessa Pharmaceuticals (CNTA) stake by 71% in Q1 2026, selling an estimated $43.1M and leaving 684,482 shares worth $27.2M. The position accounts for 0.01% of the portfolio, ranked #865.

Franklin Resources first reported a position in CNTA in Q2 2021 and has held it in 20 quarters since. The position peaked at $62M in Q3 2025. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Franklin Resources held 684,482 shares of Centessa Pharmaceuticals worth $27.2M as of Q1 2026.
  • Franklin Resources sold 1,683,899 Centessa Pharmaceuticals shares in Q1 2026, an estimated $43.1M.
  • Centessa Pharmaceuticals made up 0.01% of Franklin Resources's portfolio in Q1 2026, its #865 holding.
  • Franklin Resources first reported a position in Centessa Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • Franklin Resources's Centessa Pharmaceuticals position peaked at $62M in Q3 2025.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.